AGM/EGMMay 4, 2026, 08:12 AM
ProQR Announces June 2, 2026 AGM; Proposes Capital Increase, New Director
AI Summary
ProQR Therapeutics N.V. announced its Annual General Meeting (AGM) of Shareholders will be held on June 2, 2026, in Amsterdam. The agenda includes the adoption of 2025 annual accounts, the appointment of Dr. Lykke Hinsch Gylvin as a new non-executive board member, and the retirement of Dinko Valerio and Alison Lawton. Shareholders will also vote on increasing the authorized share capital to 270,000,000 for both ordinary and preferred shares and appointing KPMG as the auditor for 2027.
Key Highlights
- Annual General Meeting (AGM) scheduled for June 2, 2026, at 15:00 CEST.
- Proposed appointment of Dr. Lykke Hinsch Gylvin as a non-executive Board member for a 4-year term.
- Dinko Valerio and Alison Lawton will retire from the Board at the AGM.
- Proposal to increase authorized share capital to 270,000,000 for ordinary and preferred shares.
- Proposal to appoint KPMG Accountants N.V. as external auditor for financial year 2027.
- Shareholders to vote on adoption of 2025 annual accounts and appropriation of net result.
- Board authorization sought for issuing and acquiring ordinary shares.
Price Impact
More from PRQR